Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516374 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
Hard CopyAdd to Basket
Live Chat Live Help Software for Website

AMELIORATING EFFECT OF BENINCASA HISPIDA (THUNB) EXTRACTS IN COGNITIVE DYSFUNCTION IN ALZHEIMERS MODEL IN MICE. Edition No. 1

VDM Publishing House, Sep 2010, Pages: 164


  Description  
   Authors   
    
    
    
     
  Enquire before Buying   
  Send to a Friend   

Herbal preparations against human ailments are gaining importance due to the partial rejection of synthetic drugs because of their side effects. Complementary and alternative medicines may be appealing to patients due to their seemingly low side effects profile and optimistic anecdotal evidence especially when more treatments that are conventional have high failure rates or numerous side effects. Currently 80 % of the world population depends on plant-derived medicine for the first line of primary health care for human alleviation because it has no side effects. One of the folklore claim of the plant Benincasa hispida(Thunb),seems possible that treatment with oriental medicinal plants, might delay the progression of neurodegeneration through the inhibition of microglial activation. In order to contribute the medicinal potential of the plant which is not yet proven has to be investigated scientifically by new experimental models. The aim of the present investigation is to evaluate the traditional claim by using the suitable animal experimental methods and to develop a drug which will be clinically effective for the management of AD type of dementia.



For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds